A conserved antioxidant response element (ARE) in the promoter of human carbonyl reductase 3 (CBR3) mediates induction by the master redox switch Nrf2

Biochemical Pharmacology

Volumn 83, Issue 1, 2012, Pages 139-148

  Cheng, Qiuying ^a   Kalabus, James L ^a   Zhang, Jianping ^a   Blanco, Javier G ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Antioxidant response element; Carbonyl reductase 3; Nuclear factor erythroid derived 2 like 2

Indexed keywords

CARBONYL REDUCTASE; CARBONYL REDUCTASE 3; NUCLEAR PROTEIN; TERT BUTYLHYDROQUINONE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CELL CULTURE; CELL STRAIN HEPG2; CELL STRAIN MCF 7; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE CONSTRUCT; GENE DELETION; GENE INDUCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING;

ALCOHOL OXIDOREDUCTASES; ANTIOXIDANTS; CONSERVED SEQUENCE; ENZYME INDUCTION; HEP G2 CELLS; HUMANS; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS;

EID: 81855221939     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.09.027     Document Type: Article

References (36)

1. U. Oppermann Carbonyl reductases: the complex relationships of mammalian carbonyl-and quinone-reducing enzymes and their role in physiology Annu Rev Pharmacol Toxicol 47 2007 293 322
2. F. Hoffmann, and E. Maser Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily Drug Metab Rev 39 2007 87 144
3. Z. Chen, A.J. Kastaniotis, I.J. Miinalainen, V. Rajaram, R.K. Wierenga, and J.K. Hiltunen 17beta-hydroxysteroid dehydrogenase type 8 and carbonyl reductase type 4 assemble as a ketoacyl reductase of human mitochondrial FAS FASEB J 23 2009 3682 3691
4. E.S. Pilka, F.H. Niesen, W.H. Lee, Y. El-Hawari, J.E. Dunford, and G. Kochan Structural basis for substrate specificity in human monomeric carbonyl reductases PLoS One 4 2009 e7113
5. T. Miura, T. Nishinaka, and T. Terada Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1 Mol Cell Biochem 315 2008 113 121
6. J.G. Blanco, W.M. Leisenring, V.M. Gonzalez-Covarrubias, T.I. Kawashima, S.M. Davies, and M.V. Relling Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer Cancer 112 2008 2789 2795
7. O.S. Bains, M.J. Karkling, J.M. Lubieniecka, T.A. Grigliatti, R.E. Reid, and K.W. Riggs Naturally occurring variants of human CBR3 alter anthracycline in vitro metabolism J Pharmacol Exp Ther 332 2010 755 763
8. L. Fan, B.C. Goh, C.I. Wong, N. Sukri, S.E. Lim, and S.H. Tan Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity Pharmacogenet Genomics 18 2008 623 631
9. Blanco JG, Sun C-L, Landier W, Chen L, Esparza-Duran D, Leisenring W, et al. Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl-reductase genes-a report from the Children's Oncology Group. J Clin Oncol, doi:10.1200/JCO.2011.34.8987, in press.
10. J. Zhang, and J.G. Blanco Identification of the promoter of human carbonyl reductase 3 (CBR3) and impact of common promoter polymorphisms on hepatic CBR3 mRNA expression Pharm Res 26 2009 2209 2215
11. J. Cao, V. Gonzalez-Covarrubias, R.M. Straubinger, H. Wang, X. Duan, and H. Yu A rapid, reproducible, on-the-fly orthogonal array optimization method for targeted protein quantification by LC/MS and its application for accurate and sensitive quantification of carbonyl reductases in human liver Anal Chem 82 2010 2680 2689
12. R. Hu, C. Xu, G. Shen, M.R. Jain, T.O. Khor, and A. Gopalkrishnan Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice Cancer Lett 243 2006 170 192
13. H. Okawa, H. Motohashi, A. Kobayashi, H. Aburatani, T.W. Kensler, and M. Yamamoto Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity Biochem Biophys Res Commun 339 2006 79 88
14. B. Ebert, M. Kisiela, P. Malatkova, Y. El-Hawari, and E. Maser Regulation of human carbonyl reductase 3 (CBR3; SDR21C2) expression by Nrf2 in cultured cancer cells Biochemistry 49 2010 8499 8511
15. T.L. Adair-Kirk, J.J. Atkinson, G.L. Griffin, M.A. Watson, D.G. Kelley, and D. DeMello Distal airways in mice exposed to cigarette smoke: Nrf2-regulated genes are increased in Clara cells Am J Respir Cell Mol Biol 39 2008 400 411
16. R.H. Hubner, J.D. Schwartz, P. De Bishnu, B. Ferris, L. Omberg, and J.G. Mezey Coordinate control of expression of Nrf2-modulated genes in the human small airway epithelium is highly responsive to cigarette smoking Mol Med 15 2009 203 219
17. G. Shen, C. Xu, R. Hu, M.R. Jain, A. Gopalkrishnan, and S. Nair Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer chemopreventive agent curcumin Mol Cancer Ther 5 2006 39 51
18. S.K. Niture, J.W. Kaspar, J. Shen, and A.K. Jaiswal Nrf2 signaling and cell survival Toxicol Appl Pharmacol 244 2010 37 42
19. S. Dhakshinamoorthy, D.J. Long 2nd, and A.K. Jaiswal Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens Curr Top Cell Regul 36 2000 201 216
20. P. Nioi, and J.D. Hayes Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors Mutat Res: Fundam Mol Mech Mutagen 555 2004 149 171
21. E.M. Ellis Reactive carbonyls and oxidative stress: potential for therapeutic intervention Pharmacol Therapeut 115 2007 13 24
22. S.A. Bustin Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems J Mol Endocrinol 29 2002 23 39
23. E.R. Macari, and C.H. Lowrey Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway Blood 117 2011 5987 5997
24. W. Wang, and A.K. Jaiswal Nuclear factor Nrf2 and antioxidant response element regulate NRH:quinone oxidoreductase 2 (NQO2) gene expression and antioxidant induction Free Radic Biol Med 40 2006 1119 1130
25. S-i Yokota, E. Higashi, T. Fukami, T. Yokoi, and M. Nakajima Human CYP2A6 is regulated by nuclear factor-erythroid 2 related factor 2 Biochem Pharmacol 81 2011 289 294
26. K. Sankaranarayanan, and A.K. Jaiswal Nrf3 negatively regulates antioxidant-response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene J Biol Chem 279 2004 50810 50817
27. H. Yang, N. Magilnick, C. Lee, D. Kalmaz, X. Ou, and J.Y. Chan Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-kappaB and AP-1 Mol Cell Biol 25 2005 5933 5946
28. K.A. Wouters, L.C.M. Kremer, T.L. Miller, E.H. Herman, and S.E. Lipshultz Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies Br J Haematol 131 2005 561 578
29. R.D. Olson, P.S. Mushlin, D.E. Brenner, S. Fleischer, B.J. Cusack, and B.K. Chang Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol Proc Natl Acad Sci U S A 85 1988 3585 3589
30. L.E. Olson, D. Bedja, S.J. Alvey, A.J. Cardounel, K.L. Gabrielson, and R.H. Reeves Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1 Cancer Res 63 2003 6602 6606
31. G.L. Forrest, B. Gonzalez, W. Tseng, X. Li, and J. Mann Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice Cancer Res 60 2000 5158 5164
32. G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity Pharmacol Rev 56 2004 185 229
33. P. Menna, E. Salvatorelli, and G. Minotti Cardiotoxicity of antitumor drugs Chem Res Toxicol 21 2008 978 989
34. Y.J. Surh, J.K. Kundu, and H.K. Na Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals Planta Med 74 2008 1526 1539
35. M.L. Hardy, B.D. Lawenda, K.M. Kelly, E.J. Ladas, S.M. Sagar, and A. Vickers Dietary supplement use in cancer care: help or harm. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? Hematol Oncol Clin North Am 22 2008 581 617 [vii]
36. B.D. Lawenda, K.M. Kelly, E.J. Ladas, S.M. Sagar, A. Vickers, and J.B. Blumberg Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 100 2008 773 783